{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:30:14Z","timestamp":1771234214671,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902914"],"award-info":[{"award-number":["81902914"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115569","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:11:02Z","timestamp":1758600662000},"page":"115569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A rapid ex vivo co-culture of memory-like NK and activated T cells enhances anti-tumor response in gastric cancer."],"prefix":"10.1016","volume":"166","author":[{"given":"Wenxiu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manman","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baorui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115569_bb0005","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"2024-05-01;74(3):229-63","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin. [Journal Article; Research Support, Non-U.S. Gov\u2019t]"},{"key":"10.1016\/j.intimp.2025.115569_bb0010","article-title":"A cerebral clue in the stomach: brain lesion leads to discovery of hidden gastric cancer","volume":"2024-12-25;126","author":"Samani","year":"2024","journal-title":"Int J Surg Case Rep. [Case Reports; Journal Article]."},{"key":"10.1016\/j.intimp.2025.115569_bb0015","article-title":"Epidemiology of stomach cancer","volume":"2022-03-28;28(12):1187-203","author":"Ilic","year":"2022","journal-title":"World J Gastroenterol. [Journal Article; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0020","article-title":"Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells","volume":"2010-11-01;33(11):1789-95","author":"Kim","year":"2010","journal-title":"ARCH PHARM RES. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"issue":"1","key":"10.1016\/j.intimp.2025.115569_bb0025","first-page":"149","article-title":"Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells","volume":"153","author":"Uppendahl","year":"2019","journal-title":"GYNECOL ONCOL. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]"},{"key":"10.1016\/j.intimp.2025.115569_bb0030","article-title":"Cytokine-induced memory-like natural killer cells for cancer immunotherapy","volume":"2021-12-04;12(1):592","author":"Tarannum","year":"2021","journal-title":"STEM CELL RES THER. [Journal Article; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0035","article-title":"Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer","volume":"2020-12-11;370(6522):1328-34","author":"Krishna","year":"2020","journal-title":"SCIENCE. [Journal Article; Research Support, N.I.H., Intramural]."},{"key":"10.1016\/j.intimp.2025.115569_bb0040","article-title":"Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions","volume":"2022-05-01;22(5):627-41","author":"Granhoj","year":"2022","journal-title":"Expert Opin Biol Ther. [Journal Article; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0045","first-page":"17","article-title":"Designing Cancer immunotherapies that engage T cells and NK cells","volume":"2023-04-26;41","author":"Kyrysyuk","year":"2023","journal-title":"ANNU REV IMMUNOL. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0050","article-title":"CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas","volume":"2020-11-12;136(20):2308-18","author":"Gang","year":"2020","journal-title":"BLOOD. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0055","article-title":"CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas","volume":"2020-11-12;136(20):2308-18","author":"Gang","year":"2020","journal-title":"BLOOD. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]."},{"issue":"6","key":"10.1016\/j.intimp.2025.115569_bb0060","first-page":"2241","article-title":"CD28 and CD3 have complementary roles in T-cell traction forces","volume":"111","author":"Bashour","year":"2014","journal-title":"Proc Natl Acad Sci U S A. [Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov\u2019t, Non-P.H.S.]"},{"issue":"6","key":"10.1016\/j.intimp.2025.115569_bb0065","first-page":"510","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"CANCER CELL. [Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov\u2019t, Non-P.H.S.]"},{"key":"10.1016\/j.intimp.2025.115569_bb0070","article-title":"Recent advances in the tumor-penetrating peptide internalizing RGD for cancer treatment and diagnosis","volume":"2023-06-01;84(4):654-70","author":"Qian","year":"2023","journal-title":"Drug Dev Res. [Journal Article; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0075","article-title":"Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer","volume":"2017-05-01;127(5):2007-18","author":"Liu","year":"2017","journal-title":"J CLIN INVEST. [Journal Article]."},{"key":"10.1016\/j.intimp.2025.115569_bb0080","article-title":"Tumor-penetrating iRGD peptide inhibits metastasis","volume":"2015-01-01;14(1):120-8","author":"Sugahara","year":"2015","journal-title":"MOL CANCER THER. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0085","article-title":"iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma","volume":"2023-03-17;21(1):205","author":"Dong","year":"2023","journal-title":"J TRANSL MED. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0090","article-title":"iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer","volume":"2019-03-22;10(1):1336","author":"Ding","year":"2019","journal-title":"NAT COMMUN. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"issue":"10","key":"10.1016\/j.intimp.2025.115569_bb0095","first-page":"1080","article-title":"2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase\/B-cell lymphoma 2 signal pathway","volume":"25","author":"Mou","year":"2023","journal-title":"CYTOTHERAPY. [Journal Article; Research Support, Non-U.S. Gov\u2019t]"},{"key":"10.1016\/j.intimp.2025.115569_bb0100","article-title":"GMP-compliant universal antigen presenting cells (uAPC) promote the metabolic fitness and antitumor activity of Armored cord blood CAR-NK cells","volume":"2021-01-20;12","author":"Liu","year":"2021","journal-title":"FRONT IMMUNOL. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0105","article-title":"Combining AFM13, a bispecific CD30\/CD16 antibody, with cytokine-activated blood and cord blood-derived NK cells facilitates CAR-like responses against CD30(+) malignancies","volume":"2021-07-01;27(13):3744-56","author":"Kerbauy","year":"2021","journal-title":"CLIN CANCER RES. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0110","article-title":"Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1(+) CD8 T cells","volume":"2019-10-29;9(1):15527","author":"Wang","year":"2019","journal-title":"Sci Rep. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0115","first-page":"1256404","article-title":"Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function","volume":"2023-01-20;14","author":"Carreira-Santos","year":"2023","journal-title":"FRONT IMMUNOL. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"issue":"2","key":"10.1016\/j.intimp.2025.115569_bb0120","first-page":"163","article-title":"Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals","volume":"210","author":"Kristensen","year":"2022","journal-title":"CLIN EXP IMMUNOL. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]"},{"key":"10.1016\/j.intimp.2025.115569_bb0125","doi-asserted-by":"crossref","first-page":"1481745","DOI":"10.3389\/fimmu.2025.1481745","article-title":"CD94-driven in vitro expansion of highly functional adaptive NKG2C (+) NKG2A (\u2212) CD57(+) NK cells from CMV (+) healthy donors","volume":"2025-01-20;16","author":"Giordano","year":"2025","journal-title":"FRONT IMMUNOL. [Journal Article]."},{"key":"10.1016\/j.intimp.2025.115569_bb0130","article-title":"Cytokine activation induces human memory-like NK cells","volume":"2012-12-06;120(24):4751-60","author":"Romee","year":"2012","journal-title":"BLOOD. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]."},{"issue":"2","key":"10.1016\/j.intimp.2025.115569_bb0135","first-page":"e000873","article-title":"Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines","volume":"8","author":"Park","year":"2020","journal-title":"J IMMUNOTHER CANCER. [Journal Article; Research Support, Non-U.S. Gov\u2019t]"},{"key":"10.1016\/j.intimp.2025.115569_bb0140","article-title":"Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21","volume":"2022-03-01;71(3):613-25","author":"Thangaraj","year":"2022","journal-title":"Cancer Immunol Immunother. [Journal Article]."},{"key":"10.1016\/j.intimp.2025.115569_bb0145","article-title":"Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer","volume":"2015-04-01;33(4):1837-43","author":"Imamura","year":"2015","journal-title":"ONCOL REP. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0150","article-title":"Hydrogel microenvironments for cancer spheroid growth and drug screening","volume":"2018-04-01;4(4):s8998","author":"Li","year":"2018","journal-title":"SCI ADV. [Journal Article; Research Support, Non-U.S. Gov\u2019t; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0155","first-page":"24772","article-title":"Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides","volume":"2016-04-21;6","author":"Wang","year":"2016","journal-title":"Sci Rep. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0160","article-title":"Suspension culture promoted the expansion of NK-92 cells ex vivo by enhancing the expression of IL-2 receptor","volume":"2024-03-01;19(3):e2300654","author":"Huang","year":"2024","journal-title":"BIOTECHNOL J. [Journal Article]."},{"key":"10.1016\/j.intimp.2025.115569_bb0165","article-title":"Discovery and development of ANV419, an IL-2\/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy","volume":"2024-01-01;16(1):2381891","author":"Murer","year":"2024","journal-title":"MABS-AUSTIN. [Journal Article]."},{"key":"10.1016\/j.intimp.2025.115569_bb0170","doi-asserted-by":"crossref","first-page":"1435934","DOI":"10.3389\/fimmu.2024.1435934","article-title":"Preclinical delayed toxicity studies of BCMA CAR T-cell injection in B-NDG mice with multiple myeloma","volume":"2024-01-20;15","author":"Guo","year":"2024","journal-title":"FRONT IMMUNOL. [Journal Article]."},{"key":"10.1016\/j.intimp.2025.115569_bb0175","article-title":"Cytokine activation induces human memory-like NK cells","volume":"2012-12-06;120(24):4751-60","author":"Romee","year":"2012","journal-title":"BLOOD. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0180","article-title":"Cytokine-induced memory-like NK cells: from the basics to clinical applications","volume":"2022-01-20;13","author":"Terren","year":"2022","journal-title":"FRONT IMMUNOL. [Journal Article; Research Support, Non-U.S. Gov\u2019t; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0185","article-title":"Sustained effector function of IL-12\/15\/18-preactivated NK cells against established tumors","volume":"2012-12-17;209(13):2351-65","author":"Ni","year":"2012","journal-title":"J EXP MED. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0190","article-title":"A simple method for in vitro preparation of natural killer cells from cord blood","volume":"2019-11-21;19(1):80","author":"Mu","year":"2019","journal-title":"BMC BIOTECHNOL. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0195","article-title":"T cell regulation of natural killer cells","volume":"2013-06-03;210(6):1065-8","author":"Kerdiles","year":"2013","journal-title":"J EXP MED. [Journal Article; Research Support, Non-U.S. Gov\u2019t; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0200","article-title":"Mechanisms of action and overview of OKT3","volume":"1995-12-01;17(6):615-20","author":"Norman","year":"1995","journal-title":"THER DRUG MONIT. [Journal Article; Review]."},{"issue":"9","key":"10.1016\/j.intimp.2025.115569_bb0205","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/polym12091906","article-title":"iRGD Peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery","volume":"12","author":"Kang","year":"2020","journal-title":"Polymers (Basel). [Journal Article; Review]."},{"key":"10.1016\/j.intimp.2025.115569_bb0210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3389\/fimmu.2017.00675","article-title":"HLA-Bw4-I-80 isoform differentially influences clinical outcome as compared to HLA-Bw4-T-80 and HLA-A-Bw4 isoforms in rituximab or Dinutuximab-based Cancer immunotherapy","volume":"2017-01-20;8","author":"Erbe","year":"2017","journal-title":"FRONT IMMUNOL. [Journal Article]."},{"issue":"5","key":"10.1016\/j.intimp.2025.115569_bb0215","first-page":"868","article-title":"KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity","volume":"212","author":"Leijonhufvud","year":"2024","journal-title":"J IMMUNOL. [Journal Article; Research Support, Non-U.S. Gov\u2019t]"},{"key":"10.1016\/j.intimp.2025.115569_bb0220","article-title":"Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response","volume":"2021-06-14;10(1):1936392","author":"Makanga","year":"2021","journal-title":"ONCOIMMUNOLOGY. [Journal Article; Research Support, Non-U.S. Gov\u2019t]."},{"key":"10.1016\/j.intimp.2025.115569_bb0225","article-title":"KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV","volume":"2016-04-15;196(8):3398-410","author":"Boudreau","year":"2016","journal-title":"J IMMUNOL. [Journal Article; Research Support, N.I.H., Extramural]."},{"key":"10.1016\/j.intimp.2025.115569_bb0230","article-title":"A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia","author":"Nguyen","year":"2019","journal-title":"J IMMUNOTHER CANCER. [Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]"},{"issue":"1","key":"10.1016\/j.intimp.2025.115569_bb0235","first-page":"e000176","article-title":"Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial","volume":"8","author":"Nguyen","year":"2020","journal-title":"J IMMUNOTHER CANCER. [Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov\u2019t]"}],"updated-by":[{"DOI":"10.1016\/j.intimp.2025.115689","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:46:34Z","timestamp":1763696794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925015607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S1567576925015607"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115569","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid ex vivo co-culture of memory-like NK and activated T cells enhances anti-tumor response in gastric cancer.","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115569"}}